256
Views
56
CrossRef citations to date
0
Altmetric
Original Article

The Combination of Zidovudine and Interferon AIpha-2B in the Treatment of Adult T-Cell Leukemia/Lymphoma

, , , , , , , , , , , , , , , , & show all
Pages 287-294 | Received 14 Feb 2000, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ash A. Alizadeh, Sean P. Bohen, Chen Lossos, Jose A. Martinez-Climent, Juan Carlos Ramos, Elena Cubedo-Gil, William J. Harrington$suffix/text()$suffix/text() & Izidore S. Lossos. (2010) Expression profiles of adult T-cell leukemia–lymphoma and associations with clinical responses to zidovudine and interferon α. Leukemia & Lymphoma 51:7, pages 1200-1216.
Read now
Tadeusz Robak. (2008) Emerging drugs for rarer chronic lymphoid leukemias. Expert Opinion on Emerging Drugs 13:1, pages 95-118.
Read now
Styliani I Kokoris, Marina P Siakantaris, Flora N Kontopidou, Marie-Christine Kyrtsonis, Athanassios Tsakris, Nikolaos Spanakis, Konstantinos Anargyrou, Theodoros P Vassilakopoulos, Nora-Athina Viniou, Penelope Korkolopoulou, Aglaia D Dimitrakopoulou, Nikolaos Legakis & Gerassimos A Pangalis. (2004) Adult T-Cell Leukemia/Lymphoma (ATLL): Report of Two Fully Documented Hellenic Patients. Leukemia & Lymphoma 45:4, pages 715-721.
Read now

Articles from other publishers (53)

Robert Stuver, Steven M. Horwitz & Zachary D. Epstein-Peterson. (2023) Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions. Current Treatment Options in Oncology 24:8, pages 948-964.
Crossref
Smita Kumari, Sudhanshu Sharma, Dia Advani, Akanksha Khosla, Pravir Kumar & Rashmi K. Ambasta. (2021) Unboxing the molecular modalities of mutagens in cancer. Environmental Science and Pollution Research 29:41, pages 62111-62159.
Crossref
Hiba El Hajj & Ali Bazarbachi. (2022) Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia. Frontiers in Immunology 13.
Crossref
Nicolas Legrand, Skye McGregor, Rowena Bull, Sahar Bajis, Braulio Mark Valencia, Amrita Ronnachit, Lloyd Einsiedel, Antoine Gessain, John Kaldor & Marianne Martinello. (2022) Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection. Clinical Microbiology Reviews 35:2.
Crossref
Rita Hleihel, Abdou Akkouche, Hala Skayneh, Olivier Hermine, Ali Bazarbachi & Hiba El Hajj. (2021) Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities. Current Oncology Reports 23:12.
Crossref
Romain Guery, Felipe Suarez, Fanny Lanternier, Marie Elisabeth Bougnoux, Hervé Lecuyer, Véronique Avettand-Fenoel, David Sibon, Laurent Frenzel, Jean-Herlé Raphalen, Philippe Helias, Philippe Renaudier, Florin Santa, Marc Lecuit, Olivier Lortholary, Olivier Hermine, Claire Aguilar & Ambroise Marçais. (2021) Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa. Annals of Hematology 100:11, pages 2813-2824.
Crossref
Kenji Ishitsuka. (2021) Diagnosis and management of adult T-cell leukemia/lymphoma. Seminars in Hematology 58:2, pages 114-122.
Crossref
Lucy B. Cook & Adrienne A. Phillips. (2021) How I treat adult T-cell leukemia/lymphoma. Blood 137:4, pages 459-470.
Crossref
Hiba El Hajj, Kunihiro Tsukasaki, Morgane Cheminant, Ali Bazarbachi, Toshiki Watanabe & Olivier Hermine. (2020) Novel Treatments of Adult T Cell Leukemia Lymphoma. Frontiers in Microbiology 11.
Crossref
Matthew A. Lunning, Neha Mehta-Shah & Steven M. Horwitz. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1965 1974.e3 .
Neha Mehta-Shah, Lee Ratner & Steven M. Horwitz. (2017) Adult T-Cell Leukemia/Lymphoma. Journal of Oncology Practice 13:8, pages 487-492.
Crossref
Beatrice Macchi, Emanuela BalestrieriCaterina FrezzaSandro GrelliElena Valletta, Ambroise MarçaisFrancesca Marino-Merlo, Jocelyn Turpin, Charles R. Bangham, Olivier Hermine, Antonio Mastino & Ali Bazarbachi. (2017) Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α. Blood Advances 1:12, pages 748-752.
Crossref
Hiroo Katsuya & Kenji Ishitsuka. (2017) Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. Journal of Clinical and Experimental Hematopathology 57:3, pages 87-97.
Crossref
Masahiro AMANO. (2017) Cutaneous Manifestations Associated with HTLV-1 Infection (the latter part)HTLV-1 と皮膚疾患(後編). Nishi Nihon Hifuka 79:6, pages 582-588.
Crossref
Rihab Nasr, Ambroise Marçais, Olivier Hermine & Ali Bazarbachi. 2017. Human T-Lymphotropic Viruses. Human T-Lymphotropic Viruses 197 216 .
Amanda R Panfil, Michael P Martinez, Lee Ratner & Patrick L Green. (2016) Human T-cell leukemia virus-associated malignancy. Current Opinion in Virology 20, pages 40-46.
Crossref
Takashi YAMAGUCHI & Motonobu NAKAMURA. (2015) Adult T-cell Leukemia/Lymphoma (ATLL) (the latter part). Nishi Nihon Hifuka 77:5, pages 503-508.
Crossref
Olivier Hermine, Ambroise Marçais, Felipe Suarez & Ali Bazarbachi. 2015. Tropical Hemato-Oncology. Tropical Hemato-Oncology 183 197 .
Kenji Ishitsuka & Kazuo Tamura. (2014) Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. The Lancet Oncology 15:11, pages e517-e526.
Crossref
Kenneth S Charles, Niall Leelah & Desiree C Murray. (2014) Ophthalmic presentation of relapsed HTLV1- associated adult T-cell leukaemia lymphoma (ATLL) in a Trinidadian man. Tropical Doctor 44:2, pages 103-105.
Crossref
Kunihiro Tsukasaki, Toshiki Watanabe & Kensei Tobinai. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2076 2092.e4 .
Anne Cachat, Sébastien Alain Chevalier, Sandrine Alais, Nga Ling Ko, Lee Ratner, Chloé Journo, Hélène Dutartre & Renaud Mahieux. (2013) Alpha Interferon Restricts Human T-Lymphotropic Virus Type 1 and 2 De Novo Infection through PKR Activation . Journal of Virology 87:24, pages 13386-13396.
Crossref
Ambroise Marçais, Felipe Suarez, David Sibon, Laurent Frenzel, Olivier Hermine & Ali Bazarbachi. (2013) Therapeutic Options for Adult T-Cell Leukemia/Lymphoma. Current Oncology Reports 15:5, pages 457-464.
Crossref
Choei Kobatake, Masato Mizutani, Masato Amou & Satoshi Yurimoto. (2013) Pharmacological and clinical profile of mogamulizumab (POTELIGEO^|^#174; Injection). Folia Pharmacologica Japonica 141:2, pages 100-105.
Crossref
Kunihiro Tsukasaki & Kensei Tobinai. 2013. T-Cell Lymphomas. T-Cell Lymphomas 113 135 .
Amir T. Fathi, Yi-Bin Chen, Brett W. Carter & Russell J.H. Ryan. (2012) Case 24-2012. New England Journal of Medicine 367:6, pages 552-563.
Crossref
Takashi IshidaTatsuro JohNaokuni UikeKazuhito YamamotoAtae UtsunomiyaShinichiro YoshidaYoshio SaburiToshihiro MiyamotoShigeki TakemotoHitoshi SuzushimaKunihiro TsukasakiKisato NosakaHiroshi FujiwaraKenji IshitsukaHiroshi InagakiMichinori OguraShiro AkinagaMasao TomonagaKensei TobinaiRyuzo Ueda. (2012) Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study. Journal of Clinical Oncology 30:8, pages 837-842.
Crossref
Ambroise Marçais, Felipe Suarez, David Sibon, Ali Bazarbachi & Olivier Hermine. (2012) Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment. Leukemia Research and Treatment 2012, pages 1-8.
Crossref
Kunihiro Tsukasaki & Kensei Tobinai. (2012) Clinical Trials and Treatment of ATL. Leukemia Research and Treatment 2012, pages 1-12.
Crossref
Ali BazarbachiFelipe Suarez, Paul Fields & Olivier Hermine. (2011) How I treat adult T-cell leukemia/lymphoma. Blood 118:7, pages 1736-1745.
Crossref
Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker & Andrew McMillan. (2011) Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma). British Journal of Haematology 153:4, pages 451-485.
Crossref
Elaine S. Jaffe. 2011. Hematopathology. Hematopathology 521 531 .
Ali BazarbachiYves PlumelleJuan Carlos RamosPatricia TortevoyeZaher OtrockGraham TaylorAntoine GessainWilliam HarringtonGérard PanelattiOlivier Hermine. (2010) Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes. Journal of Clinical Oncology 28:27, pages 4177-4183.
Crossref
Adrienne A. Phillips, Iuliana Shapira, Robert D. Willim, Jasotha Sanmugarajah, William B. Solomon, Steven M. Horwitz, David G. Savage, Govind Bhagat, Gerald Soff, Jasmine M. Zain, Bachir Alobeid, Venkatraman E. Seshan & Owen A. O'Connor. (2010) A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma. Cancer 116:14, pages 3438-3446.
Crossref
Ghada KchourMahdi Tarhini, Mohamad-Mehdi KooshyarHiba El HajjEric WattelMahmoud MahmoudiHassan HatoumHossein RahimiMasoud Maleki, Houshang RafatpanahS. A. Rahim RezaeeMojtaba Tabatabaei YazdiAbbas ShirdelHugues de Thé, Olivier Hermine, Reza FaridAli Bazarbachi. (2009) Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Blood 113:26, pages 6528-6532.
Crossref
Jing Chen, Meili Zhang, Wei Ju & Thomas A. Waldmann. (2009) Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25. Blood 113:6, pages 1287-1293.
Crossref
Kunihiro TsukasakiOlivier HermineAli BazarbachiLee RatnerJuan Carlos RamosWilliam HarringtonJrJrDeirdre O’MahonyJohn E. JanikAchiléa L. BittencourtGraham P. TaylorKazunari YamaguchiAtae UtsunomiyaKensei TobinaiToshiki Watanabe. (2009) Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. Journal of Clinical Oncology 27:3, pages 453-459.
Crossref
Johannes Humer, Boris Ferko, Andrea Waltenberger, Ronald Rapberger, Hubert Pehamberger & Thomas Muster. (2008) Azidothymidine inhibits melanoma cell growth in vitro and in vivo. Melanoma Research 18:5, pages 314-321.
Crossref
Kenji Ishitsuka & Kazuo Tamura. (2008) Treatment of adult T-cell leukemia/lymphoma: past, present, and future. European Journal of Haematology 80:3, pages 185-196.
Crossref
A Datta & C Nicot. (2007) Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells. Oncogene 27:8, pages 1135-1141.
Crossref
Kensei Tobinai & Toshiki Watanabe. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2425 2441 .
Megan Brown, Marcia Bellon & Christophe Nicot. (2006) Emodin and DHA potently increase arsenic trioxide interferon-α–induced cell death of HTLV-I–transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1. Blood 109:4, pages 1653-1659.
Crossref
Abhik DattaMarcia BellonUma Sinha-DattaAli BazarbachiYves LepelletierDanielle CanioniThomas A. WaldmannOlivier HermineChristophe Nicot. (2006) Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108:3, pages 1021-1029.
Crossref
Claire Dearden. (2006) The Role of Alemtuzumab in the Management of T-Cell Malignancies. Seminars in Oncology 33, pages 44-52.
Crossref
Farhad Ravandi & Susan O'Brien. (2005) Chronic Lymphoid Leukemias Other Than Chronic Lymphocytic Leukemia: Diagnosis and Treatment. Mayo Clinic Proceedings 80:12, pages 1660-1674.
Crossref
Farhad Ravandi, Hagop Kantarjian, Dan Jones, Claire Dearden, Michael Keating & Susan O'Brien. (2005) Mature T‐cell leukemias. Cancer 104:9, pages 1808-1818.
Crossref
Lee Ratner. (2005) Human T cell lymphotropic virus-associated leukemia/lymphoma. Current Opinion in Oncology 17:5, pages 469-473.
Crossref
M. Dungerwalla, N. Osuji, A. D. Waldman, F. Al Jehani, A. Mehta, R. Taylor, A. Wotherspoon, G. Cogill & E. Matutes. (2005) Isolated central nervous system involvement in adult T-cell lymphoma/leukaemia. British Journal of Haematology 130:4, pages 511-515.
Crossref
Ali Bazarbachi, David Ghez, Yves Lepelletier, Rihab Nasr, Hugues de Thé, Marwan E El-Sabban & Olivier Hermine. (2004) New therapeutic approaches for adult T-cell leukaemia. The Lancet Oncology 5:11, pages 664-672.
Crossref
K. Tobinai & T. Hotta. (2004) Clinical Trials for Malignant Lymphoma in Japan. Japanese Journal of Clinical Oncology 34:7, pages 369-378.
Crossref
Takayuki Ishikawa. (2003) Current Status of Therapeutic Approaches to Adult T-Cell Leukemia. International Journal of Hematology 78:4, pages 304-311.
Crossref
Francine M. Foss, Suzanne L. Aquino & Judith A. Ferry. (2003) Case 10-2003. New England Journal of Medicine 348:13, pages 1267-1275.
Crossref
. (2001) Current Awareness in Hematological Oncology. Hematological Oncology 19:4, pages 159-166.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.